Moreover, treating HCC cells with SBI‐756, a well‐characterized eIF4G‐specific inhibitor, phenocopied eIF4G knockout by reducing cell proliferation (Figure S10d,e, Supporting Information). The gene discussed is EIF4G1; the disease is hepatocellular carcinoma.